HCA Healthcare
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track HCA Healthcare in real time with a live news feed covering HCA Healthcare stock news, official press releases, company announcements, and an archive of historical HCA Healthcare news. ...more
Loading news...
Loading more...
3:48 AM | Tuesday | Oct 20, 2026
Sign in to download news snippet
Assenagon Asset Management S.A. lifted its holdings in shares of HCA Healthcare, Inc. (NYSE: HCA) by 27.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
The fund owned 19,162 shares of the company's stock after buying an additional 4,161 shares during the
No data available for this time period.
Change the time range to see results.
Assenagon Asset Management S.A. lifted its holdings in shares of HCA Healthcare, Inc. (NYSE: HCA) by 27.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).
The fund owned 19,162 shares of the company's stock after buying an additional 4,161 shares during the
The September Jobs report was weak by many measures. The headline number showed only 29,000 private sector jobs were created, far below expectations of 84,000 and the prior 12-month average of 45,000.
Read full article
The September Jobs report was weak by many measures. The headline number showed only 29,000 private sector jobs were created, far below expectations of 84,000 and the prior 12-month average of 45,000.
Read full article
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
HCA Healthcare remains a "Buy," supported by strong revenue growth and favorable demographic trends in healthcare demand. Despite some margin pressures from payer mix shifts, HCA's revenue per equivalent admission rose 6% and occupancy improved year-over-year. Management anticipates 2026 revenue growth to $77–$79.5 billion, though net income and EBITDA guidance have been revised slightly lower.
Read full article
Terra Nova Asset Management LLC grew its holdings in HCA Healthcare, Inc. (NYSE: HCA) by 112.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,019 shares of the company's stock after purchasing an additional 1,595 shares during the quarter.
Read full article
HF Sinclair, Accenture and FirstCash post impressive gains as Zacks research portfolios highlight standout performers amid market uncertainty and shifting investor sentiment.
Read full article
I track an investable universe of 50 high-quality dividend growth stocks to identify attractive entry points based on valuation and future return potential. Applied Materials, D.R. Horton, and Home Depot saw notable ranking improvements due to upgraded EPS growth estimates and/or favorable valuation shifts. 44 out of 50 stocks currently offer a forward return estimate of at least 10%, with 32 appearing potentially undervalued based on free cash flow mean reversion.
NEW YORK, Oct. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
HCA Healthcare (NYSE: HCA - Get Free Report) and Nutex Health (NASDAQ: NUTX - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations. Analyst Ratings This is a breakdown of current
Read full article
HCA Healthcare (NYSE: HCA - Get Free Report) and Omada Health (NASDAQ: OMDA - Get Free Report) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Earnings and Valuation This table compares HCA Healthcare
Read full article
NEW YORK, Oct. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
No data available for this time period.
Change the time range to see results.